The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000911392
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
7/07/2026
Date registered
Help: Date registered
23/07/2026
Date last updated
Help: Date last updated
23/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
23/07/2026
Date results provided
Help: Date results provided
23/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Effects of fat content in a mixed-nutrient meal on tissue microvascular haemodynamics in healthy humans
Scientific title
Effects of fat content in a mixed-nutrient meal on tissue microvascular haemodynamics in healthy humans
Additional trial identifiers [1] 317377 0
2026/HE000248
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Poor tissue blood flow 342973 0
Condition category
Condition code
Diet and Nutrition 338409 338409 0 0
Other diet and nutrition disorders
Musculoskeletal 338410 338410 0 0
Other muscular and skeletal disorders
Cardiovascular 338877 338877 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
This study aims to investigate the effects of fat content in a mixed-nutrient meal on muscle and adipose tissue microvascular blood flow (MBF) in healthy humans. We will be using a pre-tested low-fat meal (control meal) that has been demonstrated to increase microvascular responses in healthy people. This meal provides 1306 kJ of energy and contains 38 g of carbohydrates, 21 g of protein and 5 g of fat.. We will compare its effects to that of a high-fat meal that provides 1680 kJ of energy and contains 38 g of carbohydrates, 21 g of protein and 15 g of fat. This study will be a repeated measures randomized cross-over design with participants coming into the laboratory for 2 visits (7 to 10 days apart). During each visit participants will consume one of the two meals (in a random order) and will undergo post-meal blood flow and metabolism assessment. The participants will be blinded to the meal type. The participants will consume the meal infront of the researchers.
Intervention code [1] 334342 0
Lifestyle
Intervention code [2] 334746 0
Treatment: Other
Description of the comparator or control
The low-fat meal group is going to be considered our control group. The low-fat meal (control meal) provides 1306 kJ of energy and contains 38 g of carbohydrates, 21 g of protein and 5 g of fat..
Control group
Active

Outcomes
Primary outcome [1] 345724 0
Skeletal muscle microvascular blood flow (MBF)
Timepoint [1] 345724 0
0 min, 60 min, and 240 min post-meal.
Secondary outcome [1] 463064 0
Brachial artery blood flow
Timepoint [1] 463064 0
0 min, 60 min, and 240 min post-meal.
Secondary outcome [2] 463068 0
Flow-mediated dilation (FMD)
Timepoint [2] 463068 0
0 min, 60 min, and 240 min post-meal.
Secondary outcome [3] 463069 0
Plasma Glucose
Timepoint [3] 463069 0
Baseline, 15, 30, 45, 60, 75, 90, 105, 120, 180, 210, and 240 min post-meal.
Secondary outcome [4] 463070 0
Resting metabolic rate
Timepoint [4] 463070 0
0 and 60 min post-meal.
Secondary outcome [5] 463071 0
Brachial blood pressure
Timepoint [5] 463071 0
0, 60, 120, and 240 min post-meal.
Secondary outcome [6] 464972 0
Femoral artery blood flow
Timepoint [6] 464972 0
0, 60, 240 mins post meal
Secondary outcome [7] 464973 0
Insulin
Timepoint [7] 464973 0
Baseline, 15, 30, 45, 60, 75, 90, 105, 120, 180, 210, and 240 min post-meal.
Secondary outcome [8] 464974 0
Plasma hormone GIP
Timepoint [8] 464974 0
Baseline, 15, 30, 45, 60, 75, 90, 105, 120, 180, 210, and 240 min post-meal.
Secondary outcome [9] 464975 0
Plasma hormone GLP-1
Timepoint [9] 464975 0
Baseline, 15, 30, 45, 60, 75, 90, 105, 120, 180, 210, and 240 min post-meal.
Secondary outcome [10] 464976 0
Serum lipids
Timepoint [10] 464976 0
Baseline, 15, 30, 45, 60, 75, 90, 105, 120, 180, 210, and 240 min post-meal.

Eligibility
Key inclusion criteria
Age 18-45 years.
Body Mass Index (BMI) 18-24.9 Kg/m2.
Normotensive (seated brachial blood pressure <140/90 mmHg).
Have no dietary allergies, food intolerances, or dietary restrictions.
Have given signed informed consent to participate in the study.
Minimum age
18 Years
Maximum age
45 Years
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
People do not meet the inclusion criteria outlined above.
People tell us they cannot read or understand the English language.
Smoking status – People who are regular smokers in the last 10 years and/or >10 years of smoking history, or who use vapes.
People have a history of severe liver disease, any vascular or cardiovascular disease, or diabetes.
Pregnant/lactating women.
People with a family history of type 2 diabetes (i.e., a parent with type 2 diabetes).
People already on a high-fat diet (e.g., keto diet), or a vegan/vegetarian diet.
People who have known food allergies, intolerances, or dietary restrictions.
People who suffer from any respiratory issues (such as asthma).
People who have previously had a reaction to the Definity contrast agent.
People who exercise more than the current guidelines for physical activity (>5 hours of moderate intensity physical activity or > 2.5 hours of vigorous intensity physical activity per week).

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The participants and the researcher analyzing the data will be blinded to the type of meal. Another researcher will randomly assign a liquid meal (in a concealed container) to participants first visit. Then the participants will receive the other liquid meal at the 2nd visit.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer-generated random sequence,
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s

The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Crossover
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 321952 0
University
Name [1] 321952 0
HDR Funds, Deakin University
Country [1] 321952 0
Australia
Primary sponsor type
University
Name
Deakin University
Address
Country
Australia
Secondary sponsor category [1] 324825 0
None
Name [1] 324825 0
Address [1] 324825 0
Country [1] 324825 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320489 0
Deakin University Human Research Ethics Committee (DUHREC)
Ethics committee address [1] 320489 0
Ethics committee country [1] 320489 0
Australia
Date submitted for ethics approval [1] 320489 0
01/06/2026
Approval date [1] 320489 0
14/07/2026
Ethics approval number [1] 320489 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150634 0
Dr Gunveen Kaur
Address 150634 0
Deakin University, 221 Burwood Highway, Burwood, VIC 3125
Country 150634 0
Australia
Phone 150634 0
+61392468288
Fax 150634 0
Email 150634 0
Contact person for public queries
Name 150635 0
Gunveen Kaur
Address 150635 0
Deakin University, 221 Burwood Highway, Burwood, VIC 3125
Country 150635 0
Australia
Phone 150635 0
+61392468288
Fax 150635 0
Email 150635 0
Contact person for scientific queries
Name 150636 0
Gunveen Kaur
Address 150636 0
Deakin University, 221 Burwood Highway, Burwood, VIC 3125
Country 150636 0
Australia
Phone 150636 0
+61392468288
Fax 150636 0
Email 150636 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: Participants will be given their individual baseline results on muscle mass, fat mass, blood glucose, serum insulin and blood lipids. All other data will only be accessible by the researchers that are named on the ethics application. Published data in research journals will only be shared in non-identifiable manner and as group average.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
TypeIs Peer Reviewed?DOICitations or Other DetailsAttachment
Plain language summaryNo PLS-Consent_Mixed Meals Study_1.6.26.docx

Documents added automatically
No additional documents have been identified.